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J A U M E  RAVENTÓS 
AND M O D E R N  
ANAESTHESIOLOGY 
JAUME R A V E N T ~ S  WILL GO DOWN IN THE HISTORY OF 
MODERN MEDICINE FOR GIVING TODAY'S SURGERY'.WHAT 
IT NEEDED IN ORDER T O  DEVELOP: WITHOUT AN 
ANAESTHETIC AGENT SUCH AS FLUOTHANE, THE SURGICAL 
TECHNIQUES EMPLOYED TODAY MIGHT NEVER HAVE BEEN 
POSSIBLE. 
aume Raventós formed part of 
the prestigious group of Catalan 
researchers who, during the pe- 
riod before the Civil War, carried out 
their work in the context of the Institut 
de Fisiologia, where together with the 
master August Pi i Sunyer they man- 
aged to raise the leve1 of this discipline 
in our country to quite remarkable 
heights. 
As a result of the war, the Institut de 
Fisiologia was forced to interrupt its 
activities indefinitely. However. the 
diaspora produced a new crop of 
thinkers who in time were themselves 
to illuminate the paths marked by their 
own footprints. 
His research work in Manchester made 
C A R L E S  H E R V A S  P U Y A 1  A N A E S T H E S I O L O G I S T .  
M E M B E R  O F  T H E  C A T A L A N  S O C I E T Y  O F  M E D I C A L  H I S T O R Y  
the name of Jaume Raventós universal, 
mainly because of his decisive contribu- 
tion to the introduction of a new anal- 
gesic inhalation called fluothane, which 
replaced ether and chloroform, thereby 
opening up new possibilities for mo- 
dern anaesthetics. Jaume Raventós will 
therefore go down in the history of mo- 
dern medicine for giving today's sur- 
gery what it needed in order to develop: 
without an anaesthetic agent such as 
fluothane, the surgical techniques em- 
ployed today might never have been 
possible. 
Jaume Raventós i Pijoan was born in 
Barcelona on 3 August 1905. He took a 
degree in medicine at the University of 
Barcelona, where he graduated in 1930. 
While he was studying, Raventós got a 
place as an interna1 student of Physio- 
logy, the start of his relations with Au- 
gust Pi i Sunyer, who was to be his 
teacher. 
Having completed his studies, he joined 
the faculty's Laboratory of Physiology 
as resident doctor. By 193 1 he was as- 
sistant teacher at practica1 classes, and a 
little while later -in 1934- he was made 
assistant teacher of Human Physiology. 
In July of the following year he moved 
to Edinburgh University, where he 
joined the Department of Pharmacol- 
ogy so as to further his research work. 
The outbreak of the Civil War, though, 
meant that his stay in the United King- 
dom, which should originally have 
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lasted a few months, was extended to 
the end of his days. 
While he was at university and at the 
Institut de Fisiologia, Raventós contri- 
buted to a number of projects, most of 
them under the guidance of his teacher 
Pi i Sunyer. Later on, he started his own 
line of investigation into the effect of 
nicotine on nervous conduction, the 
subject of the doctoral thesis he pre- 
sented in 1934. 
The first period, at the Department of 
Pharmacology of the University of 
Edinburgh under Professor A.J. Clark, 
did not involve a change in direction 
for him, since he continued to investi- 
gate the action of neurotransmitters. 
In 1939, Jaume Raventós moved to 
Manchester, where he joined the Dep- 
artment of Pharmacological Investiga- 
tion at the Imperial Chemical Indus- 
tries Laboratories (ICI), where he conti- 
nued his work until 1967. 
Throughout the forties and early fifties, 
he studied the pharmacology of various 
intravenous anaesthetics, principally of 
barbiturates like Evipan. In 1946, along 
with Carrington, he published the re- 
sults obtained with Kemithal, a new 
barbiturate which, the same as the 
others, was to be replaced by Tiobarbi- 
tal. At that time, ICI had embarked on 
a policy of research into new anaesthe- 
tic inhalants that could overcome the 
obstacles which until then had been in- 
separable from ether and chloroform. 
In this way, in 1956 Raventós made an 
exhaustive study of the pharmacologi- 
cal properties of a compound which had 
previously been synthesized by Suckling 
and which he called fluothane. Raven- 
tós showed that this product could be 
used as an anaesthetic and that it un- 
doubtedly offered important advant- 
ages such as, for example, the fact of 
not being explosive. His work made it 
possible for this medicine to be viably 
tested on humans, and we can of course 
affirm that today, following those first 
tests, millions of doses have been ad- 
ministered for purposes of anaesthesia. 
The research carried out by Jaume Ra- 
ventós earned him the recognition of 
the international scientific community. 
In 1967 he was named president of the 
Manchester Society. In 1973, together 
with Suckling, Raventós received the 
John Scott prize in Philadelphia. 
Finally, in 198 1, he was made Honorary 
Member of the Faculty of Anaesthesio- 
logists of the Royal College of Surgeons 
in England. 
In 1968, when the Societat Catalana 
dlAnestesiolegs i Reanimació decided 
to name the annual prize it awards for 
outstanding work after him, Raventós 
sent a highly emotive letter to the insti- 
tution, thanking them and expressing 
his surprise at the initiative. Raven- 
tós felt that his contribution to pro- 
gress in medicine had been "relatively 
small". 
Jaume Raventós i Pijoan died in Man- 
chester on 22 December 1982. The So- 
cietat Catalana de Biologia remembers 
this universal Catalan as an eminent 
researcher and, needless to say, as one 
of its most illustrious members. ¤ 
